| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
From the Division of Reproductive Endocrinology and Fertility, Department of Obstetrics and Gynecology, University of North Carolina School of Medicine, Chapel Hill, North Carolina
Abstract
During the five years ending on December 31, 1981, 159 anovulatory and oligomenorrheic patients were treated with clomiphene citrate for induction of ovulation. Overall, 86% of these patients ovulated, and 49% of the patients who ovulated conceived. Life table analysis was employed to investigate factors contributing to reduced conception rates, including abnormal semen analysis, pelvic or tubal abnormalities, and poor cervical mucus. Elevated serum testosterone levels did not affect conception rates. The most significant factor contributing to reduced overall pregnancy rates was patient discontinuation of therapy. Cumulative pregnancy rates corrected for discontinuation approach 100% after ten cycles of therapy. During this period, the monthly probability of pregnancy (monthly fecundability) remained constant. Optimal pregnancy rates are attained if other infertility factors are corrected and treatment is continued for ten to 12 ovulatory cycles.
This article has been cited by other articles:
|
|
 |
|
  The Thessaloniki ESHRE/ASRM-Sponsored PCOS Consens Consensus on infertility treatment related to polycystic ovary syndrome Hum. Reprod., March 1, 2008; 23(3): 462 - 477. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. S. Guzick Treating the Polycystic Ovary Syndrome the Old-Fashioned Way N. Engl. J. Med., February 8, 2007; 356(6): 622 - 624. [Full Text] [PDF]
|
|
|
|
|
|
M. J.C. Eijkemans, S. Polinder, A. G.M.G.J. Mulders, J. S.E. Laven, J.D. F. Habbema, and B. C.J.M. Fauser Individualized cost-effective conventional ovulation induction treatment in normogonadotrophic anovulatory infertility (WHO group 2) Hum. Reprod., October 1, 2005; 20(10): 2830 - 2837. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. E. Messinis Ovulation induction: a mini review Hum. Reprod., October 1, 2005; 20(10): 2688 - 2697. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Unfer, M. L. Casini, L. Costabile, M. Mignosa, S. Gerli, and G. C. Di Renzo High Dose of Phytoestrogens Can Reverse the Antiestrogenic Effects of Clomiphene Citrate on the Endometrium in Patients Undergoing Intrauterine Insemination: A Randomized Trial Reproductive Sciences, July 1, 2004; 11(5): 323 - 328. [Abstract] [PDF]
|
|
|
|
 |
|
 Managing anovulatory infertility DTB, April 1, 2004; 42(4): 28 - 32. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. J.C. Eijkemans, B. Imani, A. G.M.G.J. Mulders, J.D. F. Habbema, and B. C.J.M. Fauser High singleton live birth rate following classical ovulation induction in normogonadotrophic anovulatory infertility (WHO 2) Hum. Reprod., November 1, 2003; 18(11): 2357 - 2362. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Imani, M. J. C. Eijkemans, F. H. de Jong, N. N. Payne, P. Bouchard, L. C. Giudice, and B. C. J. M. Fauser Free Androgen Index and Leptin Are the Most Prominent Endocrine Predictors of Ovarian Response during Clomiphene Citrate Induction of Ovulation in Normogonadotropic Oligoamenorrheic Infertility J. Clin. Endocrinol. Metab., February 1, 2000; 85(2): 676 - 682. [Abstract] [Full Text]
|
|
|
|
|
|
B. Imani, M. J. C. Eijkemans, E. R. te Velde, J. D. F. Habbema, and B. C. J. M. Fauser Predictors of Chances to Conceive in Ovulatory Patients during Clomiphene Citrate Induction of Ovulation in Normogonadotropic Oligoamenorrheic Infertility J. Clin. Endocrinol. Metab., May 1, 1999; 84(5): 1617 - 1622. [Abstract] [Full Text]
|
|
|
|
|
|
B. Imani, M. J. C. Eijkemans, E. R. te Velde, J. D. F. Habbema, and B. C. J. M. Fauser Predictors of Patients Remaining Anovulatory during Clomiphene Citrate Induction of Ovulation in Normogonadotropic Oligoamenorrheic Infertility J. Clin. Endocrinol. Metab., July 1, 1998; 83(7): 2361 - 2365. [Abstract] [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
